Type 2 Diabetes Trial, Not Yet Recruiting NCT07420972 Sponsor: Medstar Health Research Institute Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Not Yet Recruiting

NCT07420972
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are pregnant with one baby (not twins or more)
  • People who have been diagnosed with Type 1 or Type 2 diabetes
  • People who have been using an insulin pump continuously under the skin for at least 2 months before their due date
  • People who have shown the ability to manage their own insulin, are familiar with how their insulin pump works, have access to the necessary supplies, and are in a stable health condition
  • People who are able to give informed consent to take part in the trial

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have a planned caesarean section without going into labour
  • People who have other serious health conditions that affect how much insulin they need (for example, those on steroid therapy)
  • People who experience a stillbirth before arriving at the hospital for delivery
  • People whose baby has been diagnosed with a known serious birth defect

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Victoria Greenberg, MD, MedStar Health

Phone: 301-782-3353

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Medstar Health Research Institute
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
1 February 2028

Primary endpoints

Feasibility Metrics

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov